TY - JOUR
T1 - Health-related quality of life in Japanese low-risk prostate cancer patients choosing active surveillance
T2 - 3-year follow-up from PRIAS-JAPAN
AU - Hirama, Hiromi
AU - Sugimoto, Mikio
AU - Miyatake, Nobuyuki
AU - Kato, Takuma
AU - Venderbos, Lionne D.F.
AU - Remmers, Sebastiaan
AU - Shiga, Kenichiro
AU - Yokomizo, Akira
AU - Mitsuzuka, Koji
AU - Matsumoto, Ryuji
AU - Osawa, Takahiro
AU - Abe, Takashige
AU - Sasaki, Hiroshi
AU - Egawa, Shin
AU - Ninomiya, Iku
AU - Hashine, Katsuyoshi
AU - Roobol, Monique J.
AU - Kakehi, Yoshiyuki
N1 - Funding Information:
We thank Drs Toshiki Tanikawa, Toshihiro Saito, Kazuhiro Kobayashi, Tadashi Matsuda, Hidefumi Kinoshita, Masatoshi Eto, Junichi Inokuchi, Akito Terai, Hirohito Naito, Yoshiko Maeda, Tomohiko Ichikawa, Masahiro Sugiura, Hiroyoshi Suzuki, Naoto Kamiya, Takumi Endo, Osamu Ogawa, Shusuke Akamatsu, Koichiro Akakura, Toshiyuki Kamoto, Naoki Terada, Isao Hara, Kazuhiro Suzuki, Hiroaki Matsumoto, Kiyotaka Kawashima, Fumimasa Fukuta, Naoya Masumori, Akira Miyajima, Masahiro Nitta, Takamitsu Inoue, Sohei Kanda, Kazuo Nishimura, Masashi Nakayama, Yasutomo Nakai, Takayuki Sugiyama, Hideaki Miyake, Norihiko Tsuchiya, Hisashi Kawazoe, Seiichi Saito, Ryu Kimura, Minoru Miyazato, Hiroomi Kanayama, Yoshito Kusuhara, Tomomi Kamba, Yoji Murakami, Haruki Kume, Masaki Nakamura, Jun Teishima, Takeshi Ueno, Mitsugu Kanehira, Norio Nonomura, Motohide Uemura, Ken-ichi Tabata, Hideyasu Tsumura, Hiroshi Okuno, Toshihiro Uchida, Osamu Ukimura, Takumi Shiraishi, Hiroshi Fukuhara, Yasuo Yamamoto, Tadashi Murata, Kazuto Ito, Yukio Kageyama, Yasuyuki Sakai, Yukio Naya, Satoko Kojima, Hiroshi Masuda, Hideki Sakai, Tomoaki Hakariya, Yoshihiko Tomita, Takashi Kasahara, Naoki Nishimoto, and Yoshio Ueno for their great contribution to this study. The authors thank all contributions for PRIAS-JAPAN.
Publisher Copyright:
© 2020, Springer-Verlag GmbH Germany, part of Springer Nature.
PY - 2021/7
Y1 - 2021/7
N2 - Purpose: To evaluate the health-related quality of life (HRQoL) of Japanese men on active surveillance (AS) in the Prostate cancer Research International Active Surveillance study in Japan (PRIAS-JAPAN). Methods: Participants were included in the PRIAS-JAPAN HRQoL study between January 2010 and March 2016. Their general HRQoL was assessed using a validated Japanese version of the Short-Form 8 Health Survey (SF-8) at enrolment and annually thereafter until discontinuation of AS. The SF-8 mental component summary (MCS) and physical component summary (PCS) of men on AS were compared with scores of the general population (norm-based score [NBS]: 50) and MCS and PCS scores for men following AS were analysed over time. We tested whether MCS and PCS scores over time explained discontinuation of AS. Results: Five hundred and twenty-five patients enrolled, and the median age at baseline was 68 years. At enrolment and after 1-, 2-, and 3-year follow-ups, the PCS and MCS scores were significantly higher than the NBS of the general Japanese population except for the median PCS at 3 years. We found that age at diagnosis and time on AS negatively affected the PCS score of men on AS, while every additional year on AS led to a 0.27 point increase in MCS scores. Neither PCS nor MCS were predictors for discontinuation of AS. Conclusion: Japanese men following an AS strategy for 3 years reported better HRQoL compared with the general population, indicating that monitoring Japanese low-risk prostate cancer patients can be an effective treatment strategy. Study registration: Clinical trial registry—UMIN (University Hospital Medical Information Network); UMIN000002874 (2009/12/11)
AB - Purpose: To evaluate the health-related quality of life (HRQoL) of Japanese men on active surveillance (AS) in the Prostate cancer Research International Active Surveillance study in Japan (PRIAS-JAPAN). Methods: Participants were included in the PRIAS-JAPAN HRQoL study between January 2010 and March 2016. Their general HRQoL was assessed using a validated Japanese version of the Short-Form 8 Health Survey (SF-8) at enrolment and annually thereafter until discontinuation of AS. The SF-8 mental component summary (MCS) and physical component summary (PCS) of men on AS were compared with scores of the general population (norm-based score [NBS]: 50) and MCS and PCS scores for men following AS were analysed over time. We tested whether MCS and PCS scores over time explained discontinuation of AS. Results: Five hundred and twenty-five patients enrolled, and the median age at baseline was 68 years. At enrolment and after 1-, 2-, and 3-year follow-ups, the PCS and MCS scores were significantly higher than the NBS of the general Japanese population except for the median PCS at 3 years. We found that age at diagnosis and time on AS negatively affected the PCS score of men on AS, while every additional year on AS led to a 0.27 point increase in MCS scores. Neither PCS nor MCS were predictors for discontinuation of AS. Conclusion: Japanese men following an AS strategy for 3 years reported better HRQoL compared with the general population, indicating that monitoring Japanese low-risk prostate cancer patients can be an effective treatment strategy. Study registration: Clinical trial registry—UMIN (University Hospital Medical Information Network); UMIN000002874 (2009/12/11)
KW - Active surveillance
KW - HRQoL
KW - Japanese cohort
KW - Low-risk prostate cancer
KW - Patient‐reported outcome measurement
UR - http://www.scopus.com/inward/record.url?scp=85092908955&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85092908955&partnerID=8YFLogxK
U2 - 10.1007/s00345-020-03494-4
DO - 10.1007/s00345-020-03494-4
M3 - Article
C2 - 33079252
AN - SCOPUS:85092908955
SN - 0724-4983
VL - 39
SP - 2491
EP - 2497
JO - World Journal of Urology
JF - World Journal of Urology
IS - 7
ER -